Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea
· Delayed Price · Currency is KRW 10,870
+370 (3.52%)
Mar 10, 2026, 1:50 PM KST
KRX:019170 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 549,046 | 539,247 | 707,263 | 1,124,818 | 1,653,859 | 6,353,533 | Upgrade
|
| Market Cap Growth | 2.76% | -23.76% | -37.12% | -31.99% | -73.97% | 1668.54% | Upgrade
|
| Enterprise Value | 539,343 | 521,260 | 679,012 | 1,050,665 | 1,521,791 | 6,168,944 | Upgrade
|
| Last Close Price | 10500.00 | 10310.00 | 13520.00 | 21150.00 | 31950.00 | 124000.00 | Upgrade
|
| PE Ratio | - | - | - | - | - | 1269.99 | Upgrade
|
| PS Ratio | 2.37 | 2.44 | 3.53 | 5.38 | 8.74 | 32.13 | Upgrade
|
| PB Ratio | 2.08 | 2.09 | 2.61 | 3.40 | 4.59 | 16.72 | Upgrade
|
| P/TBV Ratio | 2.13 | 2.14 | 2.68 | 3.49 | 4.72 | 17.12 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 364.98 | Upgrade
|
| P/OCF Ratio | - | - | - | - | - | 316.69 | Upgrade
|
| EV/Sales Ratio | 2.33 | 2.36 | 3.39 | 5.02 | 8.04 | 31.20 | Upgrade
|
| EV/EBITDA Ratio | 54.56 | - | - | - | - | 309.16 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 796.45 | Upgrade
|
| EV/FCF Ratio | -80.59 | - | - | - | - | 354.38 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.21 | 0.17 | 0.01 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 4.97 | - | - | - | - | 0.09 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.01 | -0.05 | -0.16 | -0.25 | -0.50 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.06 | 0.37 | 0.41 | 2.55 | 56.11 | -9.46 | Upgrade
|
| Net Debt / FCF Ratio | 1.57 | 0.09 | 0.36 | 1.70 | 1.21 | -10.85 | Upgrade
|
| Asset Turnover | 0.68 | 0.64 | 0.56 | 0.55 | 0.43 | 0.45 | Upgrade
|
| Inventory Turnover | 2.37 | 2.55 | 2.38 | 2.78 | 2.31 | 2.47 | Upgrade
|
| Quick Ratio | 1.86 | 1.70 | 1.86 | 5.39 | 6.39 | 3.45 | Upgrade
|
| Current Ratio | 2.74 | 2.50 | 2.60 | 7.24 | 8.16 | 4.06 | Upgrade
|
| Return on Equity (ROE) | -1.79% | -5.81% | -19.04% | -10.22% | -3.11% | 1.70% | Upgrade
|
| Return on Assets (ROA) | -0.32% | -3.08% | -8.33% | -5.60% | -2.01% | 1.10% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.68% | -6.64% | -17.78% | -12.47% | -6.22% | 2.10% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.60% | -6.40% | -17.30% | -10.20% | -3.90% | 1.90% | Upgrade
|
| Earnings Yield | -0.68% | -2.85% | -8.11% | -3.15% | -0.70% | 0.08% | Upgrade
|
| FCF Yield | -1.22% | -3.84% | -5.61% | -2.82% | -4.56% | 0.27% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.08% | Upgrade
|
| Buyback Yield / Dilution | 4.50% | - | - | - | -1.85% | -0.71% | Upgrade
|
| Total Shareholder Return | 4.50% | - | - | - | -1.85% | -0.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.